New paper in Science shows that RNAs help certain molecules come together in liquid-like protected compartments, information that could have implications for understanding neurodegenerative diseases.

Today, the majority of drugs and pharmaceuticals on the market that treat human disease are designed to target a specific protein. But University of North Carolina at Chapel Hill startup Ribometrix has a very different, revolutionary approach to new drug discovery that’s proving to be a breakthrough in the industry.